AzTrials
AzTrials

Atrioventricular BlockNCT03851315

Left Bundle Branch Area Pacing in AVB Patients

An observational study of Atrioventricular Block and Left Bundle Branch Area Pacing, run by Fu Wai Hospital, Beijing, China at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Right ventricular pacing (RVP) causes left ventricular mechanical dyssynchrony by inducing electrical interventricular and intraventricular dyssynchrony. His bundle pacing may restore the the atrioventricular, interventricular and intraventricular electrical synchronization, however, Increased pacing threshold might… Read more about this study

Who is it for?
Ages 18 to 90 yearsHealthy volunteers can take part
What is being tested?
permanent left bundle branch area pacing
Type of treatment
Medical device
How many people
45 participants
Where
1 siteChina
Study dates
1 May 2018to 30 Jun 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Consecutive AVB patients with indications for ventricular pacing according to 2013 ESC/EHRA Guidelines. Patients with persistent atrial fibrillation or indications for cardiac resynchronization therapy or implantable cardioverter defibrillator implantation , hypertrophic cardiomyopathy, myocardial amyloidosis, or refused postoperative follow-up were excluded. All patients should sign written informed consent for agreement of the implantation procedure.

Who may be able to join

  • Age over 18 years old;
  • Atrioventricular block patients with indication for permanent ventricular pacing;
  • LVEF> 40%;
  • With informed consent signed

Who cannot join

  • Persistent atrial fibrillation;
  • Moderate or more severe valvular disease;
  • Hypertrophic cardiomyopathy;
  • Myocardial amyloidosis;
  • With indication for CRT or ICD implantation according to the current guideline;
  • Poor condition of the acoustic window because of emphysema or other reasons;
  • Patients refused postoperative follow-up.

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • Fu Wai Hospital

    Beijing, Beijing Municipality, 100037

    Xiaofei Li, Master, 17801013995, lixiaofei0103@163.com

    Xiaohan Fan, MD,PhD, 13811421067, fanxiaohan@fuwaihospital.org

    Recruiting

Other trials in China

About this study

Official title: Permanent Left Bundle Branch Area Pacing for Atrioventricular Block

Right ventricular pacing (RVP) causes left ventricular mechanical dyssynchrony by inducing electrical interventricular and intraventricular dyssynchrony. His bundle pacing may restore the the atrioventricular, interventricular and intraventricular electrical synchronization, however, Increased pacing threshold might result in the early depletion of the pacemaker, and finally brought on pacemaker replacement, which was one of the major causes of device infection. Pacing the left bundle branch beyond the conduction block site might achieve a low and stable output and narrow QRSd. The investigators were prepared to consecutively include patients with atrioventricular block, divided into the left bundle branch area pacing(LBBAP) group and the conventional right ventricular pacing group. The electrophysiological characteristics of LBBAP and right ventricular pacing were compared with ECG characteristics. The left and right ventricular synchrony and left and right cardiac function were evaluated by 3D ultrasound, and the short-term and long-term safety and efficacy of LBBAP were evaluated.

Read the detailed description

This study is intended to be included in Fuwai hospital for admission to the atrioventricular block, with permanent pacemaker implant indications recommended by current guidelines. Patients were assessed for preoperative electrocardiogram, quality of life scores, cardiac function, and left and right ventricular synchrony. Patients were followed up by regular outpatients. The electrocardiogram, quality of life score, echocardiographic function, left and right ventricular synchrony, pacing parameters and pacing ratio were evaluated immediately after surgery, 3 months, 6 months, and 12 months after surgery. At the same time, the left bundle branch area pacing success rate, complications during intraoperative and postoperative follow-up were recorded.

Being tested
permanent left bundle branch area pacing
Keywords
Atrioventricular Block, left bundle branch area pacing
Medical subject headings
Atrioventricular Block

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • permanent left bundle branch area pacingDevice

    Implant the pacing lead in the left bundle branch area instead of traditional RV pacing site(septal or apical). Successful LBBAP was defined as the paced QRS morphology of right bundle branch block pattern in lead V1 and QRS duration (QRSd) less than 130ms.

Study groups in NCT03851315
Study groupRoleWhat they receive
LBBAP grouppatients received left bundle branch area pacing
Receives: Device: permanent left bundle branch area pacing
traditional RVP groupAge and sex-matched patients received traditional right ventricular pacing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The synchronization status change at 3 months and 1 year as compared with baseline status.

    Left ventricualr strain change from baseline to 3 month, from baselin to 1 year post operation.

    Measured: 3 months and 1 year

Secondary outcomes (6)
  1. Pacing threshold change at 3 months and 1 year as compared with baseline status.

    The pacing threshold changes between 3-month and baseline status, changes between 1 year and the baseline status.

    Measured: 3 months and 1 year

  2. LBBAP related adverse events at 3 months and 1 year as compared with baseline status.

    The adverse events includes perforation, acute myocardial infarction, loss of capture, increase of pacing threshold, et al. These events were evaluated at baseline, 3 months and 1 year after the procedure, respectively.

    Measured: 3 months and 1 year

  3. left ventricular ejection fraction change at 3 months and 1 year

    Left ventricular ejection fraction change from baseline to 3 month, from baselin to 1 year post operation.

    Measured: 3 months and 1 year

  4. Right ventricular ejection fraction change at 3 months and 1 year

    Right ventricular ejection fraction change from baseline to 3 month, from baselin to 1 year post operation.

    Measured: 3 months and 1 year

  5. Left ventricular end systolic diameter change at 3 months and 1 year

    Left ventricular end systolic diameter change from baseline to 3 month, from baselin to 1 year post operation.

    Measured: 3 months and 1 year

  6. Left ventricular end diastolic diameter change at 3 months and 1 year

    Left ventricular end diastolic diameter change from baseline to 3 month, from baselin to 1 year post operation.

    Measured: 3 months and 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Feb 2019
  2. Study start1 May 2018
  3. Primary completion31 Dec 2020 (estimated)
  4. Study completion30 Jun 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
45 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03851315
Sponsor's protocol ID
LBBAP-001
Status last verified
Feb 2019
First submitted
18 Feb 2019
Last updated
22 Feb 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Undecided

Publications

  • Vijayaraman P, Naperkowski A, Ellenbogen KA, Dandamudi G. Electrophysiologic Insights Into Site of Atrioventricular Block: Lessons From Permanent His Bundle Pacing. JACC Clin Electrophysiol. 2015 Dec;1(6):571-581. doi: 10.1016/j.jacep.2015.09.012. Epub 2015 Oct 17.

    PubMed 29759411
  • Huang W, Su L, Wu S, Xu L, Xiao F, Zhou X, Ellenbogen KA. A Novel Pacing Strategy With Low and Stable Output: Pacing the Left Bundle Branch Immediately Beyond the Conduction Block. Can J Cardiol. 2017 Dec;33(12):1736.e1-1736.e3. doi: 10.1016/j.cjca.2017.09.013. Epub 2017 Sep 22.

    PubMed 29173611
  • Chen K, Li Y, Dai Y, Sun Q, Luo B, Li C, Zhang S. Comparison of electrocardiogram characteristics and pacing parameters between left bundle branch pacing and right ventricular pacing in patients receiving pacemaker therapy. Europace. 2019 Apr 1;21(4):673-680. doi: 10.1093/europace/euy252.

    PubMed 30462207
  • Guo XG, Liu X, Zhou GB, Sun Q, Yang JD, Luo B, Ouyang F, Ma J, Zhang S. Clinical, electrocardiographic, and electrophysiological characteristics of left upper septal fascicular ventricular tachycardia. Europace. 2018 Apr 1;20(4):673-681. doi: 10.1093/europace/euw429.

    PubMed 28160481
  • Upadhyay GA, Cherian T, Shatz DY, Beaser AD, Aziz Z, Ozcan C, Broman MT, Nayak HM, Tung R. Intracardiac Delineation of Septal Conduction in Left Bundle-Branch Block Patterns. Circulation. 2019 Apr 16;139(16):1876-1888. doi: 10.1161/CIRCULATIONAHA.118.038648.

    PubMed 30704273
  • Li X, Zhang J, Qiu C, Wang Z, Li H, Pang K, Yao Y, Liu Z, Xie R, Chen Y, Wu Y, Fan X. Clinical Outcomes in Patients With Left Bundle Branch Area Pacing vs. Right Ventricular Pacing for Atrioventricular Block. Front Cardiovasc Med. 2021 Jul 8;8:685253. doi: 10.3389/fcvm.2021.685253. eCollection 2021.

    PubMed 34307499

Questions about this trial

What is this clinical trial studying?

An observational study of Atrioventricular Block and Left Bundle Branch Area Pacing, run by Fu Wai Hospital, Beijing, China at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The synchronization status change at 3 months and 1 year as compared with baseline status. (time frame: 3 months and 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03851315, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Feb 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in